The ABPI is at the heart of a health sector-wide effort to establish consensus on key Brexit issues including medicines regulation, UK and EU trading relationships, access to talent, and the future of UK science.
We are creating a new relationship with the European Union that secures patient access to medicines and protects public health.
A voluntary agreement between the Government and the pharmaceutical industry.
We work with the government, industry, medical charities and organisations and trade associations to support the pharmaceutical and life sciences sector.
Women leaders at AstraZeneca Macclesfield on careers in manufacturing and inspiring the next generation of #WomenInSTEM.
08 March 2018
02 March 2018
The ABPI has responded to the Prime Minister's ‘Road to Brexit’ speech today at Mansion House.
Medical and disease area information